NeuroCube® In Vivo AI Platform for Neurological Phenotyping
NeuroCube® is designed to evaluate gait to assess the impact of treatments on motor impairment disorders and pain. It provides...
Preclinical Psychedelics Research
PsychoGenics is uniquely positioned to support preclinical psychedelic research involving DEA schedule 1 drugs. We’ve established the necessary secure storage...
Validated Phenotypic Approach to Neuropsychiatric Drug Discovery
Leahy E Drug Development & Delivery March 2019 Vol 19 No 2: 46-49. At the recent American College of Neuropsychopharmacology...
Preclinical Microbiome Research
Leveraging our extensive experience working with rodent disease models, PsychoGenics offers a comprehensive suite of services that can help explore...
Stephen Morairty, Ph.D.
Dr. Stephen Morairty has over 30 years of experience in research and drug development focusing on translational neuroscience and EEG...
Christina Leahy
Christina Leahy has more than 35 years of experience in the pharmaceutical and biotechnology industries, the last 20 years with...
Thank You
Thank you for your message. Our team will be back in touch with you shortly. If you would like to...
Preclinical Parkinson’s Disease Studies
Parkinson’s disease is a chronic degenerative neurological disorder affecting millions globally. Its manifestation — the death of dopaminergic cells in...
About
PsychoGenics is the only CNS-focused contract research organization (CRO) of scale. We design and execute preclinical drug discovery and early...